{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:45:35Z","timestamp":1648737935119},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,15]]},"DOI":"10.1093\/cid\/ciaa1688","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T20:13:10Z","timestamp":1603915990000},"page":"e957-e958","source":"Crossref","is-referenced-by-count":0,"title":["Inferring Public Health Policies From Epidemiology and Whole Genome Sequencing of Invasive Pneumococcal Isolates From a Surveillance Network"],"prefix":"10.1093","volume":"72","author":[{"given":"Stephen I","family":"Pelton","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotem","family":"Lapidot","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"2021061514012533100_CIT0001","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/cid\/ciz739","article-title":"Clinical infectious diseases early impact of 13-valent pneumococcal conjugate vaccine use on invasive pneumococcal disease among adults with and without underlying medical conditions\u2014United States","volume":"70","author":"Ahmed","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021061514012533100_CIT0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/vaccines7010004","article-title":"Should pneumococcal serotype 3 be included in serotype-specific immunoassays?","volume":"7","author":"Linley","year":"2019","journal-title":"Vaccines"},{"key":"2021061514012533100_CIT0003","first-page":"1616","article-title":"Serotype 3 remains the leading cause of invasive pneumococcal disease in adults in Portugal (2012\u20132014) despite continued reductions in other 13-valent conjugate vaccine serotypes","volume":"7","author":"Peruski","year":"2010","journal-title":"Front Microbiol"},{"key":"2021061514012533100_CIT0004","doi-asserted-by":"crossref","first-page":"S467","DOI":"10.1093\/ofid\/ofx163.1194","article-title":"Impact of PCV13 on serotype 3 invasive pneumococcal disease and nasopharyngeal carriage in Massachusetts\u2019 children","volume":"4","author":"Lapidot","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2021061514012533100_CIT0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013\u201318","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"key":"2021061514012533100_CIT0006","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/315096","article-title":"Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants","volume":"180","author":"Yu","year":"1999","journal-title":"J Infect Dis"},{"key":"2021061514012533100_CIT0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41479-018-0055-4","article-title":"Streptococcus pneumoniae outbreaks and implications for transmission and control: a systematic review","volume":"10","author":"Zivich","year":"2018","journal-title":"Pneumonia"},{"key":"2021061514012533100_CIT0008","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jinf.2019.10.009","article-title":"Outbreaks of severe pneumococcal disease in closed settings in the conjugate vaccines era, 2010\u20132018: a systematic review to inform national guidance in the UK","volume":"79","author":"Amin-Chowdhury","year":"2019","journal-title":"J Infect"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1688\/35001221\/ciaa1688.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/12\/e957\/38649021\/ciaa1688.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/12\/e957\/38649021\/ciaa1688.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T14:01:52Z","timestamp":1623765712000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/12\/e957\/5957066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":8,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,11,5]]},"published-print":{"date-parts":[[2021,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1688","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,15]]},"published":{"date-parts":[[2020,11,5]]}}}